Novus Biologicals Announces New MAPKSP1 Antibody made using SDIX's Genomic Antibody Technology™

Novus Biologicals announced today a new MAP2K1IP1 Antibody for the study of cancer and signal transduction. This MAP2K1IP1 antibody was made using SDIX's Genomic Antibody TechnologyTM (GAT™).

MAP2K1IP1 is a TOR pathway regulator protein that promotes cell growth in response to certain cellular stimuli. Novus’ new MAP2K1IP1 Antibody is useful for Western blot and immunofluorescent staining of human and mouse cells and tissues.

GAT uses sophisticated bioinformatics and immunization strategies to produce high-quality antibodies that specifically bind to that region of the protein in its naturally folded form. The ability of any antibody to recognize a protein’s naturally folded state has the potential to expand an antibody’s utility to high-value applications like sandwich immunoassay, ChIP, and flow cytometry. Learn more about GAT by reading the GAT FAQ or by downloading the GAT White Paper.